PARADIGM: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.
English language survey results
Chi Pakarinen, Daphnee Pushparajah, Paula Decola, Magda Chlebus, and Suzanne Ii Read More
The PARADIGM International Liaison Group – a short-term support for our long-term goal
An editorial written by Mathieu Boudes, EPF, coordinator PARADIGM and Alexandra Moutet, UCB, member of the PARADIGM Steering CommitteeRead More
Stakeholder insights add value and are valued
PARADIGM understood from the start that the success of the initiative is dependent on a number of factors, none more important than understanding the perspectives and needs of the diverse set of stakeholders associated with the patient engagement ecosystem. These perspectives are important in the design, development, dissemination and implementation of PARADIGM; essentially these underpin the entire initiative. Read More
Latest posts
-
Why IMI PARADIGM - The academic perspective April 23,2019 -
Why IMI PARADIGM? - The research foundation perspective April 23,2019 -
Why IMI PARADIGM? – The industry perspective April 10,2019 -
Why IMI PARADIGM? – The patient perspective April 10,2019 -
The Price of Health Depends on Value March 18,2019 -
Value Creation: Making Room for Innovation March 15,2019 -
PARADIGM attends DIA Europe Conference, Vienna March 6,2019
